OmniAb (OABI) Liabilities and Shareholders Equity (2021 - 2026)

OmniAb's (OABI) quarterly Liabilities and Shareholders Equity came in at $293.6 million in Q1 2026, down 4.09% year-on-year from $306.2 million in Q1 2025, and down 2.41% on a QoQ basis from $300.9 million in Q4 2025.

OmniAb (OABI) Liabilities and Shareholders Equity (2021 - 2026) Analysis & Trends

OmniAb (OABI) has 6 years of Liabilities and Shareholders Equity data on file, last reported at $293.6 million in Q1 2026.

  • On a quarterly basis, Liabilities and Shareholders Equity fell 4.09% year-over-year to $293.6 million in Q1 2026; TTM through Mar 2026 was $1.2 billion, a 7.74% decrease from a year earlier, with the FY2025 full-year figure at $300.9 million, down 7.57% from the prior year.
  • Liabilities and Shareholders Equity for Q1 2026 stood at $293.6 million, down from $300.9 million in the prior quarter.
  • Over the last five years, Liabilities and Shareholders Equity for OABI reached as high as $421.2 million in Q4 2022 and fell as low as $236.8 million in Q2 2022.
  • Historically, Liabilities and Shareholders Equity has averaged $327.7 million across 5 years, with a median of $325.6 million in 2024.
  • Across the five-year window, Liabilities and Shareholders Equity jumped 37283.13% in 2022 and declined 16.77% in 2024, its largest moves.
  • Year by year, Liabilities and Shareholders Equity stood at $421.2 million in 2022, then dropped by 10.92% to $375.2 million in 2023, then decreased by 13.24% to $325.6 million in 2024, then decreased by 7.57% to $300.9 million in 2025, then fell by 2.41% to $293.6 million in 2026.
  • Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $293.6 million in Q1 2026, $300.9 million in Q4 2025, and $309.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 311.58 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 78.88 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 8.55 Bn
4 NuCana 279.75 Bn 279.75 Bn - 39.68 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 26.48 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 40.87 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 811.27 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 10.03 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 2.25 Bn
10 OmniAb 261.62 Mn 212.55 Mn 14.41 Mn 293.65 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 293.65 Mn
Dec 31, 2025 300.91 Mn
Sep 30, 2025 309.69 Mn
Jun 30, 2025 295.67 Mn
Mar 31, 2025 306.18 Mn
Dec 31, 2024 325.56 Mn
Sep 30, 2024 331.55 Mn
Jun 30, 2024 337.26 Mn
Mar 31, 2024 352.56 Mn
Dec 31, 2023 375.23 Mn
Sep 30, 2023 391.71 Mn
Jun 30, 2023 405.24 Mn
Mar 31, 2023 413.04 Mn
Dec 31, 2022 421.21 Mn
Sep 30, 2022 237.61 Mn
Jun 30, 2022 236.79 Mn
Mar 31, 2022 236.90 Mn
Dec 31, 2021 304.47 Mn
Sep 30, 2021 236.99 Mn
Jun 30, 2021 633,415.00